Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:HUM
  • CUSIP: 44485910
  • Web:
  • Market Cap: $34.55262 billion
  • Outstanding Shares: 144,517,000
Average Prices:
  • 50 Day Moving Avg: $250.95
  • 200 Day Moving Avg: $232.23
  • 52 Week Range: $163.50 - $259.76
  • Trailing P/E Ratio: 19.77
  • Foreward P/E Ratio: 19.52
  • P/E Growth: 1.55
Sales & Book Value:
  • Annual Revenue: $53.87 billion
  • Price / Sales: 0.64
  • Book Value: $75.79 per share
  • Price / Book: 3.15
  • Annual Dividend: $1.60
  • Dividend Yield: 0.7%
  • EBIDTA: $2.66 billion
  • Net Margins: 3.37%
  • Return on Equity: 15.85%
  • Return on Assets: 5.76%
  • Debt-to-Equity Ratio: 0.39%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
  • Average Volume: 1.09 million shs.
  • Beta: 0.87
  • Short Ratio: 3.51

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, August 17th. Investors of record on Tuesday, August 29th will be paid a dividend of $0.40 per share on Friday, October 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, September 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has authorized a share buyback program on Tuesday, April 11th 2017, which authorizes the company to buyback $2,250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 7.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Wednesday, August, 2nd. The company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.08 by $0.41. The firm earned $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the previous year, the business earned $2.30 earnings per share. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Friday, September, 1st. The company provided EPS guidance of ~$11.50 for the period, compared to the Thomson Reuters consensus estimate of $11.51.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

19 brokerages have issued 12-month price targets for Humana's shares. Their forecasts range from $200.00 to $280.00. On average, they expect Humana's share price to reach $245.94 in the next twelve months. View Analyst Ratings for Humana.

Are investors shorting Humana?

Humana saw a decline in short interest in August. As of August 31st, there was short interest totalling 2,679,854 shares, a decline of 36.0% from the August 15th total of 4,190,098 shares. Based on an average daily volume of 864,285 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.9% of the shares of the company are sold short.

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board
  • Bruce D. Broussard, President, Chief Executive Officer, Director
  • Brian A. Kane, Chief Financial Officer, Senior Vice President
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Who owns Humana stock?

Humana's stock is owned by a number of of institutional and retail investors. Top institutional investors include Capital World Investors (9.16%), BlackRock Inc. (7.76%), Vanguard Group Inc. (6.85%), FMR LLC (4.52%), State Street Corp (4.24%) and Capital Research Global Investors (2.70%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Capital World Investors, BlackRock Inc., Third Point LLC, Steadfast Capital Management LP, Prudential Financial Inc., Capital Guardian Trust Co. and Davidson Kempner Capital Management LP. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, FMR LLC, Koch Industries Inc., Acadian Asset Management LLC, TIAA CREF Investment Management LLC, Ameriprise Financial Inc., Capital Research Global Investors and UBS Asset Management Americas Inc.. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $239.09.

MarketBeat Community Rating for Humana (NYSE HUM)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  530 (Vote Outperform)
Underperform Votes:  627 (Vote Underperform)
Total Votes:  1,157
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $245.94 (2.87% upside)

Analysts' Ratings History for Humana (NYSE:HUM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/20/2017Cowen and CompanyReiterated RatingOutperform$230.00 -> $275.00MediumView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$269.00 -> $276.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$234.00 -> $243.00LowView Rating Details
8/4/2017Jefferies Group LLCReiterated RatingHold$257.00LowView Rating Details
8/3/2017Cantor FitzgeraldReiterated RatingNeutral$200.00 -> $223.00LowView Rating Details
8/3/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$236.00 -> $255.00MediumView Rating Details
8/3/2017Credit Suisse GroupReiterated RatingOutperform$250.00 -> $260.00HighView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
6/5/2017Royal Bank Of CanadaReiterated RatingHold$214.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017Barclays PLCReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna Bancshares IncReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
11/10/2016J P Morgan Chase & CoUpgradeNeutral -> Overweight$163.00 -> $202.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 9/25/2015 forward)


Earnings History for Humana (NYSE:HUM)
Earnings by Quarter for Humana (NYSE:HUM)
Earnings History by Quarter for Humana (NYSE HUM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017$3.25N/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Humana (NYSE:HUM)
2017 EPS Consensus Estimate: $10.86
2018 EPS Consensus Estimate: $12.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.18$3.44$3.30
Q4 20174$2.05$2.56$2.22
Q1 20181$2.74$2.74$2.74
Q2 20181$3.41$3.41$3.41
Q3 20181$3.58$3.58$3.58
Q4 20181$2.47$2.47$2.47
(Data provided by Zacks Investment Research)


Current Dividend Information for Humana (NYSE:HUM)
Next Dividend:10/27/2017
Annual Dividend:$1.60
Dividend Yield:0.67%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:13.06% (Trailing 12 Months of Earnings)
13.86% (Based on This Year's Estimates)
13.06% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE HUM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)
Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 95.12%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)
Insider Trades by Quarter for Humana (NYSE:HUM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.00View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.42View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.58View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.00View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.20View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.00View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.00View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
DateHeadline logoU.S. Senate opposition to Obamacare repeal bill grows - September 24 at 6:27 PM logoHumana Ranks No. 3 among America's Healthiest 100 Workplaces - Business Wire (press release) - September 23 at 12:22 AM logoWhy Humana is paying docs to join elite corporate training program - Louisville Business First - September 23 at 12:22 AM logoHumana scores really high in this ranking of the country's healthiest employers - Louisville Business First - September 23 at 12:22 AM logoHealthcare stocks are rising after John McCain dealt a major blow to the Republican healthcare bill - September 22 at 7:20 PM logoHumana and Humana Foundation Offer Support to Puerto Rico Communities Severely Impacted by Multiple Hurricanes - September 22 at 2:19 PM logoHumana Ranks No. 3 among America’s Healthiest 100 Workplaces - September 22 at 2:19 PM logoHumana scores really high in this ranking of the country's healthiest employers - September 22 at 2:19 PM logoPartners in Primary Care to Open Senior-focused Medical Center in Gastonia - September 20 at 3:58 PM logoHumana, Inc. breached its 50 day moving average in a Bearish Manner : HUM-US : September 20, 2017 - September 20 at 3:58 PM logoCowen and Company Reaffirms "Outperform" Rating for Humana Inc. (HUM) - September 20 at 3:52 PM logoPublic Exchange Woes Hit Health Insurers: Stocks in Focus - Nasdaq - September 20 at 5:49 AM logoHumana Inc. (HUM) Short Interest Down 36.0% in August - September 20 at 2:20 AM logoHumana Enters Oversold Territory (HUM) - Nasdaq - September 19 at 7:43 PM logoHumana wants to hire 50 people for its Tricare operations - Louisville Business First - September 19 at 7:43 PM logoObamacare enrollment to fall in 2018 and beyond after cuts: CBO - Reuters - September 14 at 10:07 PM logoJoint Studies Suggest Relationship Between TV Age Bias and Health of Seniors - September 14 at 6:13 AM logoPartners in Primary Care to Open Four Senior-focused Medical Centers in Kansas and Missouri - September 14 at 6:13 AM logoHumana Earns Gold Status in American Heart Association’s Workplace Health Achievement Index - September 13 at 5:37 AM logoHumana Foundation Donates $1000000 to Support Hurricane Irma Relief - Business Wire (press release) - September 13 at 12:36 AM logoHumana Earns Gold Status in American Heart Association's Workplace Health Achievement Index - Business Wire (press release) - September 13 at 12:36 AM logoHumana (HUM) Up 6.4% Since Earnings Report: Can It Continue? - Nasdaq - September 12 at 1:08 AM logoHumana to support Hurricane Irma relief with big grant - September 11 at 8:06 PM logoHumana (HUM) Up 6.4% Since Earnings Report: Can It Continue? - September 11 at 8:06 PM logoHumana Foundation Donates $1,000,000 to Support Hurricane Irma Relief - September 11 at 8:06 PM logo Brokerages Anticipate Humana Inc. (HUM) Will Announce Quarterly Sales of $13.29 Billion - September 10 at 11:02 AM
News IconNew York City comptroller wields new clout in boardroom diversity drive - Business Insider - September 8 at 8:50 PM logoNew York City comptroller wields new clout in boardroom diversity drive - September 8 at 8:50 PM logoHumana Offers Support to Floridians Affected by Hurricane Irma - September 8 at 8:50 PM logoHumana Inc. (HUM) Expected to Post Earnings of $3.23 Per Share - September 8 at 2:26 AM logoHumana Offers Support to Puerto Rico Communities Impacted by Hurricane Irma - Business Wire (press release) - September 8 at 12:58 AM logoEXCLUSIVE: Humana moving hundreds of jobs out of Cincinnati - Cincinnati Business Courier - September 7 at 5:42 AM logoHumana's 2017 Corporate Social Responsibility Progress Report Highlights Company's Work to 'Inspire Health' - Business Wire (press release) - September 7 at 12:38 AM logoHumana’s 2017 Corporate Social Responsibility Progress Report Highlights Company’s Work to ‘Inspire Health’ - September 6 at 7:35 PM logoElizabeth D. Bierbower Sells 9,786 Shares of Humana Inc. (HUM) Stock - September 6 at 1:22 PM logoTimothy S. Huval Sells 7,803 Shares of Humana Inc. (HUM) Stock - September 5 at 1:16 PM logoHumana Inc. (HUM) Raised to Buy at ValuEngine - September 3 at 9:06 AM
News IconAnthem cuts back Obamacare coverage in Missouri to 68 counties - Business Insider - September 2 at 11:38 PM logoHumana Inc. (HUM) Receives Average Rating of "Buy" from Analysts - September 2 at 9:08 AM logoHumana (HUM) to Reaffirm Guidance in Meetings with Investors - September 1 at 8:00 PM logoHumana Inc. (HUM) Releases FY17 Earnings Guidance - September 1 at 5:20 PM logoCramer's lightning round: My playbook for Boeing - CNBC - September 1 at 12:40 AM logoMedicare Advantage companies could face greater government scrutiny - Louisville Business First - September 1 at 12:40 AM logoHumana cuts at-home care jobs in Louisville, nationally - Louisville Business First - September 1 at 12:40 AM logoHumana cuts at-home care jobs in Louisville, nationally - August 31 at 7:37 PM logoCramer's lightning round: My playbook for Boeing - August 31 at 7:37 PM logoHumana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook - Nasdaq - August 31 at 5:56 AM logoHumana Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare Conference - August 31 at 5:56 AM logoUnitedHealth Shows Its Dealmaking Smarts Again - Bloomberg - August 30 at 1:16 AM logoHumana (HUM) Completes Accelerated Share Repurchase Program - August 29 at 12:17 AM



Humana (HUM) Chart for Monday, September, 25, 2017

This page was last updated on 9/25/2017 by Staff